TABLE OF CONTENTS
|  | | | | Volume 118, Issue 2 (145-307)
Published online 23 January 2018
|  | In this issue
 Review
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics
Epidemiology
Corrigenda
Errata
Also new today
 Advance online publication
Digital Edition
| | | | Review | Top | | How the evolution of multicellularity set the stage for cancer Anna S Trigos, Richard B Pearson, Anthony T Papenfuss and David L Goode Br J Cancer 2018 118: 145-152; advance online publication, January 16, 2018; 10.1038/bjc.2017.398 Abstract | Full Text | | Clinical Studies | Top | | Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours Jeffrey R Infante, Ronald L Korn, Lee S Rosen, Patricia LoRusso, Samuel S Dychter, Joy Zhu, Daniel C Maneval, Ping Jiang, H Michael Shepard, Gregory Frost, Daniel D Von Hoff, Mitesh J Borad and Ramesh K Ramanathan Br J Cancer 2018 118: 153-161; advance online publication, September 26, 2017; 10.1038/bjc.2017.327 Abstract | Full Text | | | | Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study Leigh G Seamon, James J Java, Bradley J Monk, Richard T Penson, Jubilee Brown, Robert S Mannel, Anna Oaknin, Mario M Leitao, Eric L Eisenhauer, Harry J Long, Shu Y Liao and Krishnansu S Tewari Br J Cancer 2018 118: 162-170; advance online publication, November 28, 2017; 10.1038/bjc.2017.400 Abstract | Full Text | | | | Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma Yuki Kitano, Hirohisa Okabe, Yo-ichi Yamashita, Shigeki Nakagawa, Yoichi Saito, Naoki Umezaki, Masayo Tsukamoto, Takanobu Yamao, Kensuke Yamamura, Kota Arima, Takayoshi Kaida, Tatsunori Miyata, Kosuke Mima, Katsunori Imai, Daisuke Hashimoto, Yoshihiro Komohara, Akira Chikamoto, Takatoshi Ishiko and Hideo Baba Br J Cancer 2018 118: 171-180; advance online publication, November 9, 2017; 10.1038/bjc.2017.401 Abstract | Full Text | | | | Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response Angela Lamarca, Jorge Barriuso, Matthew Kulke, Ivan Borbath, Heinz-Josef Lenz, Jean Luc Raoul, Neal J Meropol, Catherine Lombard-Bohas, James Posey, Sandrine Faivre, Eric Raymond and Juan W Valle Br J Cancer 2018 118: 181-188; advance online publication, November 21, 2017; 10.1038/bjc.2017.402 Abstract | Full Text | | Translational Therapeutics | Top | | Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation Amanda R Noble, Norman J Maitland, Daniel M Berney and Martin G Rumsby Br J Cancer 2018 118: 189-199; advance online publication, November 14, 2017; 10.1038/bjc.2017.391 Abstract | Full Text | | | | The combined activation of KCa3.1 and inhibition of Kv11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells Serena Pillozzi, Massimo D'Amico, Gianluca Bartoli, Luca Gasparoli, Giulia Petroni, Olivia Crociani, Tiziano Marzo, Angela Guerriero, Luigi Messori, Mirko Severi, Roberto Udisti, Heike Wulff, K George Chandy, Andrea Becchetti and Annarosa Arcangeli Br J Cancer 2018 118: 200-212; advance online publication, November 21, 2017; 10.1038/bjc.2017.392 Abstract | Full Text | | | | Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression Eiji Kashiwagi, Satoshi Inoue, Taichi Mizushima, Jinbo Chen, Hiroki Ide, Takashi Kawahara, Leonardo O Reis, Alexander S Baras, George J Netto and Hiroshi Miyamoto Br J Cancer 2018 118: 213-223; advance online publication, November 9, 2017; 10.1038/bjc.2017.393 Abstract | Full Text | | Molecular Diagnostics | Top | | ALDH1A3 affects colon cancer in vitro proliferation and invasion depending on CXCR4 status Hailiang Feng, Yanyan Liu, Xiaocui Bian, Fangying Zhou and Yuqin Liu Br J Cancer 2018 118: 224-232; advance online publication, December 12, 2017; 10.1038/bjc.2017.363 Abstract | Full Text | | | | BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM Fang Wei, Yingfen Wu, Le Tang, Yi He, Lei Shi, Fang Xiong, Zhaojian Gong, Can Guo, Xiayu Li, Qianjin Liao, Wenling Zhang, Ming Zhou, Bo Xiang, Xiaoling Li, Yong Li, Guiyuan Li, Wei Xiong and Zhaoyang Zeng Br J Cancer 2018 118: 233-247; advance online publication, November 9, 2017; 10.1038/bjc.2017.385 Abstract | Full Text | | | | Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma? Jane Margetts, Laura F Ogle, Stephen L Chan, Anthony W H Chan, K C Allen Chan, David Jamieson, Catherine E Willoughby, Derek A Mann, Caroline L Wilson, Derek M Manas, Winnie Yeo and Helen L Reeves Br J Cancer 2018 118: 248-257; advance online publication, November 9, 2017; 10.1038/bjc.2017.386 Abstract | Full Text | | | | MYC regulation of glutamine–proline regulatory axis is key in luminal B breast cancer Madeleine L Craze, Hayley Cheung, Natasha Jewa, Nuno D M Coimbra, Daniele Soria, Rokaya El-Ansari, Mohammed A Aleskandarany, Kiu Wai Cheng, Maria Diez-Rodriguez, Christopher C Nolan, Ian O Ellis, Emad A Rakha and Andrew R Green Br J Cancer 2018 118: 258-265; advance online publication, November 23, 2017; 10.1038/bjc.2017.387 Abstract | Full Text | | Genetics & Genomics | Top | | Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition Christos Mikropoulos, Christina G Hutten Selkirk, Sibel Saya, Elizabeth Bancroft, Emily Vertosick, Tokhir Dadaev, Charles Brendler, Elizabeth Page, Alexander Dias, D Gareth Evans, Jeanette Rothwell, Lovise Maehle, Karol Axcrona, Kate Richardson, Diana Eccles, Thomas Jensen, Palle J Osther, Christi J van Asperen, Hans Vasen, Lambertus A Kiemeney, Janneke Ringelberg, Cezary Cybulski, Dominika Wokolorczyk, Rachel Hart, Wayne Glover, Jimmy Lam, Louise Taylor, Monica Salinas, Lidia Feliubadaló, Rogier Oldenburg, Ruben Cremers, Gerald Verhaegh, Wendy A van Zelst-Stams, Jan C Oosterwijk, Jackie Cook, Derek J Rosario, Saundra S Buys, Tom Conner, Susan Domchek, Jacquelyn Powers, Margreet GEM Ausems, Manuel R Teixeira, Sofia Maia, Louise Izatt, Rita Schmutzler, Kerstin Rhiem, William D Foulkes, Talia Boshari, Rosemarie Davidson, Marielle Ruijs, Apollonia TJM Helderman-van den Enden, Lesley Andrews, Lisa Walker, Katie Snape, Alex Henderson, Irene Jobson, Geoffrey J Lindeman, Annelie Liljegren, Marion Harris, Muriel A Adank, Judy Kirk, Amy Taylor, Rachel Susman, Rakefet Chen-Shtoyerman, Nicholas Pachter, Allan Spigelman, Lucy Side, Janez Zgajnar, Josefina Mora, Carole Brewer, Neus Gadea, Angela F Brady, David Gallagher, Theo van Os, Alan Donaldson, Vigdis Stefansdottir, Julian Barwell, Paul A James, Declan Murphy, Eitan Friedman, Nicola Nicolai, Lynn Greenhalgh, Elias Obeid, Vedang Murthy, Lucia Copakova, John McGrath, Soo-Hwang Teo, Sara Strom, Karin Kast, Daniel A Leongamornlert, Anthony Chamberlain, Jenny Pope, Anna C Newlin, Neil Aaronson, Audrey Ardern-Jones, Chris Bangma, Elena Castro, David Dearnaley, Jorunn Eyfjord, Alison Falconer, Christopher S Foster, Henrik Gronberg, Freddie C Hamdy, Oskar Johannsson, Vincent Khoo, Jan Lubinski, Eli Marie Grindedal, Joanne McKinley, Kylie Shackleton, Anita V Mitra, Clare Moynihan, Gad Rennert, Mohnish Suri, Karen Tricker, The IMPACT study collaborators91, Sue Moss, Zsofia Kote-Jarai, Andrew Vickers, Hans Lilja, Brian T Helfand and Rosalind A Eeles Br J Cancer 2018 118: 266-276; advance online publication, January 4, 2018; 10.1038/bjc.2017.429 Abstract | Full Text | | | | MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours Diego A Garcia-Dios, Dina Levi, Vandna Shah, Cheryl Gillett, Michael A Simpson, Andrew Hanby, Ian Tomlinson and Elinor J Sawyer Br J Cancer 2018 118: 277-284; advance online publication, January 9, 2018; 10.1038/bjc.2017.450 Abstract | Full Text | | Epidemiology | Top | | Risk-adjusted colorectal cancer screening using the FIT and routine screening data: development of a risk prediction model Jennifer Anne Cooper, Nick Parsons, Chris Stinton, Christopher Mathews, Steve Smith, Stephen P Halloran, Sue Moss and Sian Taylor-Phillips Br J Cancer 2018 118: 285-293; advance online publication, November 2, 2017; 10.1038/bjc.2017.375 Abstract | Full Text | | | | Tetracycline use and risk of incident skin cancer: a prospective study Wen-Qing Li, Aaron M Drucker, Eunyoung Cho, Francine Laden, Trang VoPham, Suyun Li, Martin A Weinstock and Abrar A Qureshi Br J Cancer 2018 118: 294-298; advance online publication, October 26, 2017; 10.1038/bjc.2017.378 Abstract | Full Text | | | | The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort Daisuke Kawakita, Yuan-Chin Amy Lee, Lisa H Gren, Saundra S Buys, Carlo La Vecchia and Mia Hashibe Br J Cancer 2018 118: 299-306; advance online publication, November 21, 2017; 10.1038/bjc.2017.383 Abstract | Full Text | | Corrigenda | Top | | No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy Alexandra K Walker, Christiana Kartsonaki, Elena Collantes, Judith Nicholson, Duncan C Gilbert and Anne E Kiltie Br J Cancer 2018 118: e1; advance online publication, January 11, 2018; 10.1038/bjc.2017.410 Full Text | | | | The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma Rachna T Shroff, Mark Yarchoan, Ashley O'Connor, Denise Gallagher, Marianna L Zahurak, Gary Rosner, Chimela Ohaji, Susan Sartorius-Mergenthaler, Rose Parkinson, Vivek Subbiah, Ralph Zinner and Nilofer S Azad Br J Cancer 2018 118: e2; advance online publication, January 9, 2018; 10.1038/bjc.2017.418 Full Text | | | | Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours Jeffrey R Infante, Ronald L Korn, Lee S Rosen, Patricia LoRusso, Samuel S Dychter, Joy Zhu, Daniel C Maneval, Ping Jiang, H Michael Shepard, Gregory Frost, Daniel D Von Hoff, Mitesh J Borad and Ramesh K Ramanathan Br J Cancer 2018 118: e3; 10.1038/bjc.2017.438 Full Text | | Errata | Top | | Evidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia Stephanie A Schubert, Dina Ruano, Fadwa A Elsayed, Arnoud Boot, Stijn Crobach, Arantza Farina Sarasqueta, Bruce Wolffenbuttel, Melanie M van der Klauw, Jan Oosting, Carli M Tops, Ronald van Eijk, Hans FA Vasen, Rolf HAM Vossen, Maartje Nielsen, Sergi Castellví-Bel, Clara Ruiz-Ponte, Ian Tomlinson, Malcolm G Dunlop, Pavel Vodicka, Juul T Wijnen, Frederik J Hes, Hans Morreau, Noel FCC de Miranda, Rolf H Sijmons and Tom van Wezel Br J Cancer 2018 118: e4; advance online publication, October 12, 2017; 10.1038/bjc.2017.380 Full Text | | | | HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer Tristan A Barnes and Eitan Amir Br J Cancer 2018 118: e5; advance online publication, January 9, 2018; 10.1038/bjc.2017.417 Full Text | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. |  | | | | |
No comments:
Post a Comment